Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pharmacological profile of new acetylcholinesterase inhibitor: T-82

Sep. 3, 1998

Therapeutics for cerebrovascular disorders in development at Nippon Chemiphar

Sep. 3, 1998

Compounds interacting with nicotinic receptors for cognitive and memory deficits

Sep. 2, 1998

Anticonvulsant benzamides prepared at SKB

Sep. 2, 1998

Cambridge NeuroScience announces advances in MS program

Sep. 2, 1998

Betaseron to receive fast track review in Canada

Sep. 2, 1998

Lamotrigine approved for new indication in the U.S.: Lennox-Gastaut syndrome

Sep. 2, 1998

PD-165167 shows excellent selectivity for dopamine D4 receptors

Sep. 1, 1998

Vertex, Schering AG form strategic alliance to develop neurologic drugs

Aug. 31, 1998

Orion and Novartis agree on the distribution of entacapone

Aug. 31, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...